Key facts
- This page summarizes David Natan's Form 3 filing for Indaptus Therapeutics, Inc. (INDP).
- 0 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 12 Jan 2026, 16:05.
David Natan - 08 Jan 2026 Form 3 Insider Report for Indaptus Therapeutics, Inc. (INDP)
- Reporting relationship
- Director
- Issuer ticker
- INDP
- Reported as of
- 08 Jan 2026
- Net transaction value
- $0
- SEC form
- 3
- Accepted by SEC
- 12 Jan 2026, 16:05:07 UTC
- Prior SEC filing
- 22 Jan 2026
- Next SEC filing
- 01 Apr 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ David Natan
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
David Natan filed Form 3 for Indaptus Therapeutics, Inc. (INDP) on 12 Jan 2026.
Change
- Previous filing in this sequence was filed on 22 Jan 2026.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reporting Owners (1)
CIK 0001253108
Primary reporting owner
NATAN DAVID
- Relationship
- Director
- Address
- C/O INDAPTUS THERAPEUTICS, INC., 3 COLUMBUS CIRCLE 15TH FLOOR, NEW YORK
- Signature
- /s/ David Natan
- Signature date
- 12 Jan 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
INDP
holding
No securities are beneficially owned.
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 0
- Date
- 08 Jan 2026
- Ownership
- Direct
* marks a reported price that did not pass the local price check.